Powerweb lunch lecture Presenting scientific posters 09 April
2015
Slide 2
What to expect? About me Your poster Audience and location
Product positioning Content Design rules Posters
Slide 3
About me
Slide 4
Wow, a poster presentation! One-to-one interaction Lively
informal discussion Interact with people from other fields Ample
time to link you to your research
Slide 5
What does your stage look like?
Slide 6
Expand your audience
Slide 7
The brain acts a filter Total communication Perceived
communication
Slide 8
Getting into their minds
Slide 9
Preparing your poster Think about 2/3 prevailing messages max
~800 words graphs are better than tables 1.5m x 2.5 m or 90 cm x 90
cm? Use proper software (e.g. Adobe InDesign, Illustrator) Set a
timeline for development, review & print Handouts
Slide 10
Design start with general layout The title is large and easy to
read from a distance Authors and affiliations preferably placed
underneath the title
Slide 11
Design start with general layout The title is large and easy to
read from a distance Authors and affiliations preferably placed
underneath the title
Slide 12
Design start with general layout
Slide 13
Content Concise title Introduction preferably with bullets
Intro to field Challenge Possible solution Aim
Slide 14
Content M&M and results Only essential information Leave
out details Just mention standard assays/procedures Stand-alone
Figures
Slide 15
Visuals say more than a thousand words
Slide 16
Slide 17
Content - Conclusion Main conclusions Contribution to the field
Future directions
Slide 18
Use grids Align text and figures, horizontally and vertically
Introduction CD22 is also found highly expressed on most malignant
mature B cells, including follicular lymphoma (FL), marginal zone
lymphoma (MZL), mantle cell lymphoma (MCL), diffuse large B-cell
lymphoma (DLBCL), small lymphocytic lymphoma (SLL) and chronic
lymphocytic leukemia (CLL) [2, 3]. Moreover, CD22 is expressed in
> 90% of cases of B- precursor acute lymphoblastic leukemia
(ALL) [4]. CD22 is a type-I transmembrane sialoglycoprotein, whose
expression is restricted to the B-cell lineage [1]. CD22 is also
found highly expressed on most malignant mature B cells, including
follicular lymphoma (FL), marginal zone lymphoma (MZL), mantle cell
lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), small
lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL)
[2, 3]. Figure A. Figure shows all effects of sialoglycoprotein,
whose expression is restricted to cells of the B-lineage.
